Lechleider Robert has filed 4 insider transactions across 1 company since October 2023.
Most recent transaction: a grant/award of 242000 shares of Immunome Inc. ($IMNM) on July 29, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 29, 2025 | Immunome Inc. | $IMNM | Lechleider Robert | Chief Medical Officer | A | Employee Stock Option (right to buy) | 242000 | $0.00 | 242,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 21, 2024 | Immunome Inc. | $IMNM | Lechleider Robert | Chief Medical Officer | P | Common Stock | 15805 | $9.48 | 15,805.0000 | 0 | 9999.99% | 0.00% |
| Aug. 9, 2024 | Immunome Inc. | $IMNM | Lechleider Robert | Chief Medical Officer | A | Stock option (right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2023 | Immunome Inc. | $IMNM | Lechleider Robert | Chief Medical Officer | A | Stock option (right to buy) | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |